Purchase Order 75D30125P20607

Award Date 9/8/25
Potential Completion Date 11/15/25
Potential Value $61K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $54,350.44 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the procurement of Luminex's proprietary MagPlex-C Microsphere Beads, which are a specialized laboratory instrument used in the CDC's serological assays to quantify antibodies for public health surveillance. The CDC requires these beads due to their...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $7,950.00 firm fixed-price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of diagnostic technologies, for an annual service contract for Luminex 200 equipment. The contract, which runs through April 29, 2025, does not have a small business set-aside designation. Luminex is an established federal contractor, holding several indefinite delivery vehicles (IDVs) with agencies like the U.S....
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp., a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $38,171.76, is for the delivery of various Luminex-branded supplies and reagents, including sheath fluid, microspheres, and calibration/verification kits, to be used with the Luminex LX200 multiplex platform at the CDC's NCID San Juan Laboratories in Puerto Rico. The...
This is a $23,850 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of LUMINEX 200 SERVICE, with a period of performance through July 2027. Luminex Corporation is the prime contractor and holds several significant federal contract vehicles with the USDA and Department of Veterans Affairs for its specialized...
This is a $20,791.54 firm-fixed price purchase order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the delivery of MICROSPHERE, MAGPLEXAVIDIN, REG 026, 1ML to the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract has a completion date of September 30, 2024 and was awarded on September 12, 2024. There is no set-aside designation for this award. Luminex has provided various diagnostic testing...
This is a $97,636.38 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the provision of lab supplies, and is not set aside. Luminex has previously provided the CDC, as well as other federal agencies like the Department of Veterans Affairs and Department of Defense, with immunology services, laboratory supplies,...
This is a $248,971.98 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of Luminex Beads, with no set-aside designation. Luminex is a prime contractor that provides specialized multiplex diagnostic platforms, assays, reagents, and services to federal agencies including the CDC, VA, DHA,...
The Centers for Disease Control and Prevention (CDC) awarded a $77,468.82 firm fixed price purchase order to Luminex Corporation for MAGPIX and reagent lab supplies. The CDC, located within the Department of Health and Human Services, will utilize these products to support its infectious disease prevention and control programs conducted from its Pittsburgh location. Luminex will deliver the requested supplies from its production facilities in Austin, Texas by October 27, 2023 to meet the CDC's...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...

This is a $60,520 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a foreign-owned manufacturer of advanced biological testing technologies. The contract is for the acquisition of two Luminex MAGPIX xPONENT Systems, specialized analytical laboratory equipment well-suited for use in the CDC's Biosafety Level 3 (BSL-3) laboratories.

The procurement was conducted as a sole source acquisition under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), as the CDC determined that Luminex Corporation is the only responsible source that can provide the required instruments. The MAGPIX systems are necessary due to their compact, lightweight design that enables safe operation within biosafety cabinets and compatibility with decontamination processes, as well as to maintain consistency of results and enable comparison with historical data across different CDC laboratories. The contract has a period of performance through November 15, 2025, and there is no small business set-aside designation.

Generated 9/10/25, 9:57 AM